Smart Implantable Pumps Market: By Product Type (Micro-Pumps and Perfusion Pumps), By Application (Cardiovascular, Pain, and Spasticity), By End User (Ambulatory Surgical Centers, Hospitals, and Others), and Geography  

Smart Implantable Pumps Market size was valued at USD 1500 million in 2022 and is expected to reach a value of USD 2621 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029  owing to increasing prevalence and incidence rate of chronic diseases coupled with growing geriatric population across the globe are the major factors driving the growth of the market. Furthermore, advancements in healthcare setup and rising number of patient population with chronic pain and other chronic diseases are expected to boost the growth of the market. For instance, in the U.S., around 20% to 30% of the population experiences chronic or recurring pain. Moreover, the rising adoption of infusion pumps or implantable pumps which are small-sized medical devices is the major factor that fuels the growth of the market over the forecast period. However, increasing product recalls and stringent regulatory policies for the approval of the products are anticipated to restrain the growth of the market. The report studies global smart implantable pumps market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global smart implantable pumps market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment hot spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global smart implantable pumps products.